Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
NeoGenomics Schedules its First Quarter 2021 Earnings Release for May 5, 2021

FT MYERS, FL / ACCESSWIRE / April 7, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to...

NEO : 47.66 (-1.06%)
Strength Seen in NeoGenomics (NEO): Can Its 7.9% Jump Turn into More Strength?

NeoGenomics (NEO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

NEO : 47.66 (-1.06%)
Resilient Dow Stays at Record Despite Margin Call Volatility

Resilient Dow Stays at Record Despite Margin Call Volatility

VLO : 71.14 (+0.07%)
TMHC : 31.97 (+1.04%)
DB : 12.38 (+0.49%)
AXL : 9.39 (-1.68%)
AA : 31.40 (+0.13%)
CVA : 13.82 (-0.36%)
GRPN : 46.71 (-4.15%)
REZI : 27.88 (-0.64%)
X : 21.15 (-3.95%)
TAL : 58.47 (-0.07%)
NEO : 47.66 (-1.06%)
TDC : 39.76 (-0.38%)
CS : 10.73 (+0.75%)
NMR : 5.37 (-0.74%)
BetterLife Added to Horizons Psychedelic Stock Index ETF

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB : BETRF / FRA: NPAU) is pleased to announce that it has been added to the Horizons Psychedelic Stock Index ETF (PSYK : NEO), the...

BETRF : 0.7683 (-5.08%)
NEO : 47.66 (-1.06%)
Algernon Pharmaceuticals Announces its Addition to the Market's First Psychedelic Stock Index ETF

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the "Company" or "Algernon") a clinical stage pharmaceutical development company is pleased to announce that it has been added...

AGN.CN : 0.190 (unch)
AGNPF : 0.1509 (-0.92%)
NEO : 47.66 (-1.06%)
Horizons ETFs Completes Rebalance of World's First Psychedelics ETF

Horizons ETFs Completes Rebalance of World's First Psychedelics ETF

NEO : 47.66 (-1.06%)
NeoGenomics Agrees to Acquire Trapelo Health

Clinical Decision Support to Enable Precision Oncology

NEO : 47.66 (-1.06%)
Stocks Slip on One-Year Anniversary of Pandemic Low

Stocks Slip on One-Year Anniversary of Pandemic Low

GCI : 5.23 (+0.77%)
FI : 3.49 (-1.69%)
EMKR : 6.00 (-3.69%)
ADSK : 294.80 (-0.93%)
NEO : 47.66 (-1.06%)
TDC : 39.76 (-0.38%)
ILMN : 398.49 (-1.21%)
MOGO : 10.17 (-3.88%)
Thinking about trading options or stock in Crowdstrike Holdings, NeoGenomics, General Electric, Mcdonald's, or Wells Fargo?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CRWD, NEO, GE, MCD, and WFC.

NEO : 47.66 (-1.06%)
CRWD : 204.55 (+0.92%)
GE : 13.58 (-0.15%)
MCD : 231.26 (-0.10%)
WFC : 40.66 (+0.40%)
NeoGenomics and Elevation Oncology Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study

Clinical Trial Matching Collaboration Will Enhance Identification of Patients with Any Solid Tumor Harboring an NRG1 Gene Fusion Identified Using NeoGenomics' Advanced Gene Fusion Panels

FSNN : 0.0580 (-19.44%)
NEO : 47.66 (-1.06%)
Elevation Oncology and NeoGenomics Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study

and , /PRNewswire/ -- , a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, and  (NASDAQ:NEO), a leading provider...

FSNN : 0.0580 (-19.44%)
NEO : 47.66 (-1.06%)
Abaxx Technologies Inc. to commence trading on the OTCQB

Abaxx Technologies Inc., (ABXX:NEO)(ABXXF:OTCQB) ("Abaxx" or the "Company"), a financial software (fintech) company, majority shareholder of Abaxx Singapore Pte. Ltd., the Abaxx Commodity Exchange (ACX),...

RILY : 61.78 (+0.60%)
ABXXF : 3.0800 (-4.05%)
NEO : 47.66 (-1.06%)
Zilliqa Capital Launches a New Approach to Grow Southeast Asian Financial Ecosystem

Zilliqa Capital Pte. Ltd., the Singapore-based technology company whose objective is to become the central business and investment hub for the high-performance, high-security blockchain platform Zilliqa...

NEO : 47.66 (-1.06%)
NeoGenomics To Participate In The Virtual Raymond James 42nd Annual Institutional Investors Conference

FT. MYERS, FL / ACCESSWIRE / March 1, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...

NEO : 47.66 (-1.06%)
NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference

FT. MYERS, FL / ACCESSWIRE / February 25, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...

NEO : 47.66 (-1.06%)
NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter

NEO : 47.66 (-1.06%)
NeoGenomics Announces CEO Succession

Mark Mallon named CEO effective April 2021; Douglas M. VanOort will retire as CEO and transition to executive chairman of the board of directors

IRWD : 10.17 (-0.20%)
NEO : 47.66 (-1.06%)
NeoGenomics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 24, 2021 / NeoGenomics, Inc. (NASDAQ:NEO) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 24, 2021 at 8:30...

NEO : 47.66 (-1.06%)
NeoGenomics to Participate in the BTIG Virtual Medtech, Digital Health, Life Science & Diagnostic Tools Conference

FT. MYERS, FL / ACCESSWIRE / February 16, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...

NEO : 47.66 (-1.06%)
NASDAQ Closes Above 14K on Fourth Day of Record Highs

NASDAQ Closes Above 14K on Fourth Day of Record Highs

FLL : 9.32 (-1.89%)
SON : 64.79 (+1.03%)
VIVO : 24.11 (-3.71%)
PENN : 101.65 (-2.37%)
OSTK : 73.40 (+2.37%)
SQQQ : 11.17 (+0.90%)
NEO : 47.66 (-1.06%)
APHA : 13.87 (-14.80%)
AYX : 85.66 (+0.23%)
TAL : 58.47 (-0.07%)
GDRX : 40.67 (+1.30%)
ARTL : 1.3900 (-8.55%)
ARMK : 39.47 (+1.49%)
INTU : 415.93 (-0.40%)
MAR : 148.77 (+0.20%)
CGC : 27.54 (-5.00%)
KO : 53.26 (+0.15%)
UBER : 59.56 (+3.26%)
GM : 59.79 (-0.62%)
CME : 204.22 (-0.20%)

Barchart Exclusives

Silver Sits Near Its Midpoint As It Digests The Move Over The Past Year
Silver is sitting at just under $25 per ounce. The medium-term trend remains higher. Moreover, inflationary pressures and rising industrial applications point to a continuation of bullish price action in the volatile precious metal. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar